A detailed history of Bowen Hanes & CO Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Bowen Hanes & CO Inc holds 211,488 shares of ZTS stock, worth $37.2 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
211,488
Previous 232,713 9.12%
Holding current value
$37.2 Million
Previous $40.3 Million 2.42%
% of portfolio
1.09%
Previous 1.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$172.58 - $196.48 $3.66 Million - $4.17 Million
-21,225 Reduced 9.12%
211,488 $41.3 Million
Q2 2024

Aug 12, 2024

SELL
$145.54 - $178.83 $17.3 Million - $21.3 Million
-119,189 Reduced 33.87%
232,713 $40.3 Million
Q1 2024

May 13, 2024

BUY
$165.67 - $199.94 $248,339 - $299,710
1,499 Added 0.43%
351,902 $59.5 Million
Q4 2023

Feb 12, 2024

BUY
$151.44 - $200.09 $517,319 - $683,507
3,416 Added 0.98%
350,403 $69.2 Million
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $169,814 - $195,854
1,016 Added 0.29%
346,987 $60.4 Million
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $215,498 - $249,361
1,339 Added 0.39%
345,971 $59.6 Million
Q1 2023

May 11, 2023

SELL
$145.48 - $175.02 $894,701 - $1.08 Million
-6,150 Reduced 1.75%
344,632 $57.4 Million
Q4 2022

Feb 09, 2023

BUY
$131.14 - $157.47 $3.02 Million - $3.62 Million
23,005 Added 7.02%
350,782 $51.4 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $2.7 Million - $3.32 Million
18,175 Added 5.87%
327,777 $48.6 Million
Q2 2022

Aug 12, 2022

BUY
$155.97 - $200.09 $651,954 - $836,376
4,180 Added 1.37%
309,602 $53.2 Million
Q1 2022

May 12, 2022

SELL
$181.39 - $234.03 $506,078 - $652,943
-2,790 Reduced 0.91%
305,422 $57.6 Million
Q4 2021

Feb 11, 2022

SELL
$193.69 - $247.03 $8.07 Million - $10.3 Million
-41,684 Reduced 11.91%
308,212 $75.2 Million
Q3 2021

Nov 15, 2021

SELL
$189.29 - $209.69 $1.05 Million - $1.17 Million
-5,564 Reduced 1.57%
349,896 $67.9 Million
Q2 2021

Aug 12, 2021

SELL
$155.9 - $187.99 $417,812 - $503,813
-2,680 Reduced 0.75%
355,460 $66.2 Million
Q1 2021

May 13, 2021

BUY
$144.0 - $169.39 $87,984 - $103,497
611 Added 0.17%
358,140 $56.4 Million
Q4 2020

Feb 08, 2021

SELL
$157.07 - $174.35 $162,724 - $180,626
-1,036 Reduced 0.29%
357,529 $59.2 Million
Q3 2020

Nov 02, 2020

BUY
$137.1 - $165.37 $52,098 - $62,840
380 Added 0.11%
358,565 $59.3 Million
Q2 2020

Aug 14, 2020

SELL
$111.92 - $142.53 $3.2 Million - $4.07 Million
-28,550 Reduced 7.38%
358,185 $49.1 Million
Q1 2020

May 14, 2020

BUY
$92.66 - $144.94 $2.55 Million - $3.99 Million
27,520 Added 7.66%
386,735 $45.5 Million
Q4 2019

Feb 13, 2020

SELL
$116.25 - $133.25 $3.3 Million - $3.79 Million
-28,430 Reduced 7.33%
359,215 $47.5 Million
Q3 2019

Nov 13, 2019

SELL
$112.57 - $128.43 $2.07 Million - $2.36 Million
-18,373 Reduced 4.53%
387,645 $48.3 Million
Q2 2019

Aug 13, 2019

BUY
$97.98 - $114.28 $207,717 - $242,273
2,120 Added 0.52%
406,018 $46.1 Million
Q1 2019

May 13, 2019

BUY
$81.56 - $100.67 $1.29 Million - $1.59 Million
15,821 Added 4.08%
403,898 $40.7 Million
Q4 2018

Feb 13, 2019

BUY
$79.28 - $95.27 $172,830 - $207,688
2,180 Added 0.56%
388,077 $33.2 Million
Q3 2018

Nov 08, 2018

BUY
$83.5 - $93.23 $253,840 - $283,419
3,040 Added 0.79%
385,897 $35.3 Million
Q2 2018

Aug 14, 2018

SELL
$79.9 - $89.2 $221,323 - $247,084
-2,770 Reduced 0.72%
382,857 $32.6 Million
Q1 2018

May 15, 2018

BUY
$71.51 - $84.69 $134,796 - $159,640
1,885 Added 0.49%
385,627 $32.2 Million
Q4 2017

Feb 13, 2018

BUY
$63.24 - $72.8 $3.89 Million - $4.48 Million
61,480 Added 19.08%
383,742 $27.6 Million
Q3 2017

Nov 13, 2017

BUY
$59.73 - $65.4 $19.2 Million - $21.1 Million
322,262
322,262 $20.5 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Bowen Hanes & CO Inc Portfolio

Follow Bowen Hanes & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowen Hanes & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bowen Hanes & CO Inc with notifications on news.